- Home
- POLA vs PSTV Comparison
POLA vs PSTV Comparison
Compare POLA & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- PSTV
- Stock Information
- Founded
- POLA 1979
- PSTV 1996
- Country
- POLA United States
- PSTV United States
- Employees
- POLA N/A
- PSTV N/A
- Industry
- POLA Industrial Machinery/Components
- PSTV Medical/Dental Instruments
- Sector
- POLA Miscellaneous
- PSTV Health Care
- Exchange
- POLA Nasdaq
- PSTV Nasdaq
- Market Cap
- POLA N/A
- PSTV 9.4M
- IPO Year
- POLA 2016
- PSTV N/A
- Fundamental
- Price
- POLA $0.45
- PSTV $1.41
- Analyst Decision
- POLA
- PSTV Strong Buy
- Analyst Count
- POLA 0
- PSTV 2
- Target Price
- POLA N/A
- PSTV $14.00
- AVG Volume (30 Days)
- POLA 454.1K
- PSTV 84.6K
- Earning Date
- POLA 11-12-2024
- PSTV 10-29-2024
- Dividend Yield
- POLA N/A
- PSTV N/A
- EPS Growth
- POLA N/A
- PSTV N/A
- EPS
- POLA N/A
- PSTV N/A
- Revenue
- POLA $11,950,000.00
- PSTV $5,509,000.00
- Revenue This Year
- POLA $6.72
- PSTV $11.13
- Revenue Next Year
- POLA N/A
- PSTV N/A
- P/E Ratio
- POLA N/A
- PSTV N/A
- Revenue Growth
- POLA N/A
- PSTV 113.20
- 52 Week Low
- POLA $0.32
- PSTV $0.97
- 52 Week High
- POLA $0.98
- PSTV $2.78
- Technical
- Relative Strength Index (RSI)
- POLA 49.24
- PSTV 46.79
- Support Level
- POLA $0.44
- PSTV $1.20
- Resistance Level
- POLA $0.54
- PSTV $1.45
- Average True Range (ATR)
- POLA 0.07
- PSTV 0.10
- MACD
- POLA -0.01
- PSTV 0.01
- Stochastic Oscillator
- POLA 20.00
- PSTV 57.37
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).